Market closed

STAAR/$STAA

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About STAAR

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

Ticker

$STAA

Sector

Health Care

Trading on

NASDAQ

Industry

Health Care Equipment & Supplies

Headquarters

Lake Forest, United States

Employees

1,057

Website

www.staar.com

STAAR Metrics

BasicAdvanced

$1.1B

51.10 $0.44

0.60 -

Price and volume

Market cap

$1.1B

Beta

0.6

52-week high

$52.68

52-week low

$21.64

Average daily volume

620K

Financial strength

Current ratio

5.986

Quick ratio

5.185

Long term debt to equity

8.265

Total debt to equity

9.343

Management effectiveness

Return on assets (TTM)

3.39%

Return on equity (TTM)

5.40%

Valuation

Price to earnings (TTM)

51.103

Price to revenue (TTM)

3.229

Price to book

2.59

Price to tangible book (TTM)

2.6

Price to free cash flow (TTM)

41.901

Growth

Revenue change (TTM)

10.01%

Earnings per share change (TTM)

9.97%

3-year revenue growth (CAGR)

16.20%

3-year earnings per share growth (CAGR)

-2.13%

What the Analysts think about STAAR

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for STAAR stock.

STAAR Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

STAAR Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

STAAR News

AllArticlesVideos

STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript

Seeking Alpha·3 months ago

CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results

Business Wire·3 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $STAA

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for STAAR stock?

STAAR (STAA) has a market cap of $1.1B as of January 15, 2025.

What is the P/E ratio for STAAR stock?

The price to earnings (P/E) ratio for STAAR (STAA) stock is 51.1 as of January 15, 2025.

Does STAAR stock pay dividends?

No, STAAR (STAA) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next STAAR dividend payment date?

STAAR (STAA) stock does not pay dividends to its shareholders.

What is the beta indicator for STAAR?

STAAR (STAA) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.